These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2757770)

  • 1. Assessment of topical therapy of the burn wound with silver sulphadiazine after its use for 15 years in a burn unit.
    Koo DS; Zhen S; Zhen ZD; Shi XW; Xiang SJ
    Burns; 1989 Jun; 15(3):193-6. PubMed ID: 2757770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing.
    Robb EC; Nathan P
    J Trauma; 1981 Oct; 21(10):889-93. PubMed ID: 7277534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis.
    Snelling CF; Ronald AR; Waters WR; Yaworski DS; Drulak K; Sunderland M
    Can Med Assoc J; 1978 Sep; 119(5):466-70. PubMed ID: 99223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue deposition of silver following topical use of silver sulphadiazine in extensive burns.
    Wang XW; Wang NZ; Zhang OZ; Zapata-Sirvent RL; Davies JW
    Burns Incl Therm Inj; 1985 Feb; 11(3):197-201. PubMed ID: 3986644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic absorption of sulphadiazine, silver sulphadiazine and sodium sulphadiazine through human burn wounds.
    Aoyama H; Yokoo K; Fujii K
    Burns; 1990 Jun; 16(3):163-5. PubMed ID: 2383353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a multicenter outpatient burn study on the safety and efficacy of Dimac-SSD, a new delivery system for silver sulfadiazine.
    Deitch EA; Sittig K; Heimbach D; Jordan M; Cruse W; Kahn A; Achauer B; Finley R; Matsuda T; Salisbury R
    J Trauma; 1989 Apr; 29(4):430-4. PubMed ID: 2651681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human pharmacology of silver sulphadiazine (AgSD).
    Fox CL
    Burns Incl Therm Inj; 1985 Apr; 11(4):306-7. PubMed ID: 4005650
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective comparison of silver sulfadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent (Silvazine) and silver sulfadiazine 1 per cent (Flamazine) as prophylaxis against burn wound infection.
    Inman RJ; Snelling CF; Roberts FJ; Shaw K; Boyle JC
    Burns Incl Therm Inj; 1984 Oct; 11(1):35-40. PubMed ID: 6391611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents.
    Modak SM; Fox CL
    Arch Surg; 1981 Jul; 116(7):854-7. PubMed ID: 6455105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term experience with 1 per cent topical silver sulphadiazine cream in the management of burn wounds.
    Sawhney CP; Sharma RK; Rao KR; Kaushish R
    Burns; 1989 Dec; 15(6):403-6. PubMed ID: 2516445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary report on the spray application of topical silver sulfadiazine to burn wounds.
    Denny AD; Twomey JA; Hitchcock CR
    J Trauma; 1978 Oct; 18(10):730-1. PubMed ID: 702612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukopenia in non-septic burn patients receiving topical 1% silver sulfadiazine cream therapy: a survey.
    Fuller FW; Engler PE
    J Burn Care Rehabil; 1988; 9(6):606-9. PubMed ID: 3220867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electron-microscopic observation on silver deposition in burn wounds treated with silver sulphadiazine cream.
    Akahane T; Tsukada S
    Burns Incl Therm Inj; 1982 Mar; 8(4):271-3. PubMed ID: 7066725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silver Sulfadiazine Encapsulated in Lipid-Based Nanocarriers for Burn Treatment.
    Razavi H; Darvishi MH; Janfaza S
    J Burn Care Res; 2018 Apr; 39(3):319-325. PubMed ID: 28661974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient tolerance study of topical chlorhexidine diphosphanilate: a new topical agent for burns.
    Miller LM; Loder JS; Hansbrough JF; Peterson HD; Monafo WW; Jordan MH
    Burns; 1990 Jun; 16(3):217-20. PubMed ID: 2383364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Local therapy of grade IIa burns: efficacy and tolerability of a new hydrosome wound gel for the local treatment of grade IIa burns as compared with silver sulfadiazine ointment].
    Hauser J; Rossbach O; Langer S; Vogt P; Germann G; Steinau HU; Reimer K; Hopp M; Langer-Brauburger B; Bosse B; Homann HH
    Unfallchirurg; 2007 Nov; 110(11):988-94. PubMed ID: 17989948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of zinc sulfadiazine and silver sulfadiazine in burn wound infection.
    Fox CL; Rao TN; Azmeth R; Gandhi SS; Modak S
    J Burn Care Rehabil; 1990; 11(2):112-7. PubMed ID: 2335547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A laboratory method to evaluate formulation effects on the in vitro antimicrobial activity of topical creams and ointments.
    Love D; Kubey W; Holmes CJ
    Burns Incl Therm Inj; 1987 Jun; 13(3):204-7. PubMed ID: 3300889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of topically applied silver sulphadiazine plus cerium nitrate in major burns.
    Wassermann D; Schlotterer M; Lebreton F; Levy J; Guelfi MC
    Burns; 1989 Aug; 15(4):257-60. PubMed ID: 2765148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Our experience with the use of cerium sulphadiazine in the treatment of extensive burns.
    Koller J; Orsag M
    Acta Chir Plast; 1998; 40(3):73-5. PubMed ID: 9782621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.